ERIC HAGOOD: Open Payments
NPI 1205375318 · ALBERTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 53 payments from 16 companies in 2025. Trend: 2023 $700 · 2024 $798 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $237 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $98 |
| AstraZeneca Pharmaceuticals LP | 6 | $92 |
| Indivior Inc. | 3 | $88 |
| Novo Nordisk Inc | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Braeburn Inc. | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $37 |
| PFIZER INC. | 2 | $32 |
Products named: VRAYLAR, UBRELVY, SUBLOCADE, RELISTOR, Ozempic, Kerendia, BRIXADI, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
